EIF4A1 and neuroblastoma: Furthermore, we aimed to elucidate the effect of targeting eIF4AI in NB cell lines in order to gain insight into the relevance of using the synthetic rocaglate CR-1-31-B as a potential anti-neoplastic drug in NB.